CBOEFinancialsCommodity Contracts Brokers & DealersNEW YORK, NY

21Shares XRP ETF TOXR

Ask your AI

Estimated market cap $109.62M11.02M shares, shares as of Nov 5, 2026CIK 2028835

Insider trades, 12 mo

—

No open-market trades

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q2 2026

8.4% of shares · 0 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

IPO prospectus

Updated

21Shares XRP ETF’s initial public offering: where it stands and what the registration statement says.

Updated · Proposed ticker TOXR · First filed Nov 1, 2024

Registered

the maximum in the fee table, not the amount raised

Read from the S-1/A filed Dec 8, 2025 · Read it on sec.gov ↗

Summary text goes here once it has loaded.
Summary text goes here once it has loaded.
Summary text goes here once it has loaded. Summary text goes here once it has loaded.
Summary text goes here once it has loaded.
Summary text goes here once it has loaded.

AI summary of the prospectus. Written by AI from the parts of the prospectus listed in the filing, and checked against its text. This is information, not investment advice.

All filings of this IPO Read the S-1/A on sec.gov ↗

IPO prospectus

21Shares XRP ETF’s initial public offering: where it stands and what the registration statement says.

Loading…

Latest 10-Q

Q3 2026

What changed in 21Shares XRP ETF's latest quarterly report, compared with the one before.

Filed Nov 10, 2026 · Quarter ended Sep 30, 2026

AI No AI summary for this 10-Q: management's discussion could not be compared, and the other sections did not change.

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: risk factors and legal proceedings.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in 21Shares XRP ETF's latest quarterly report, compared with the one before.

Loading…

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No recent insider purchases or sales for this company.

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

925,943 shares

5 funds report TOXR. Values checked against market prices.

Reports for the quarter ending Sep 30, 2026 are still coming in (2 positions so far, against 5 the quarter before), so we compare the two complete quarters before it.

Q2 2026. 2 new, 0 added to, 2 trimmed, 1 exited since Q1 2026.

Top 13F holders
#
1	Goldman Sachs Group Inc 13F ↗	806,126	$8.2M	New
2	Jane Street Group, LLC 13F ↗	64,529	$656.9K	-35.9%
3	Flow Traders U.S. LLC 13F ↗	34,088	$347.0K	-59.5%
4	Teucrium Investment Advisors, LLC 13F ↗	13,100	$133.4K	New
5	Blue Trust, Inc. 13F ↗	8,100	$82.5K	unchanged

One of these funds reports its values in thousands of dollars; its figures are shown in dollars.

Download CSV Every fund that holds TOXR, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What 21Shares XRP ETF and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What 21Shares XRP ETF and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q4 2025	2	—	2.01M	$35.9M
Q1 2026	4	+2	480,254	$6.3M
Q2 2026	5	+1	925,943	$9.4M
Q3 2026	2	-3	23,711	$343.7K

Each point is a quarter-end, from Q4 2025 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (90137T103). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q4 2025) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakesNone in 12 mo 8-K events1 in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record IPO history1 registration Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: 21Shares XRP ETF
Address: 477 MADISON AVENUE, 6TH FLOOR, NEW YORK, NY 10022
Phone: 646-370-6016
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company, emerging growth company
Incorporated in: DE
Listed as: TOXR (CBOE)
Former names: 21Shares Core XRP Trust (until 2024)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$9.95−$0.13 (−1.25%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $9.95 · High $13.51Nov 13, 2026

Aug 13, 2026Low $9.71 · High $15.49Nov 13, 2026

Dec 11, 2025Low $9.71 · High $22.59Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.